Xenon(XENE) - 2024 Q4 - Annual Results

Xenon Reports Fourth Quarter & Full Year 2024 Financial Results and Business Update VANCOUVER, BC and BOSTON, MA, February 27, 2025 – Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, today provided a business update and reported financial results for the fourth quarter and full year ended December 31, 2024. "We expect the next 12 to 24 months will represent a catal ...